Xcout Intel
Avicenna Biosciences, Inc.
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
Subscribe to see Avicenna Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Avicenna Biosciences, Inc. at a glance
Avicenna Biosciences, Inc. is a biotechnology company headquartered in United States. It has raised at least $17.6M across the 5 funding rounds on record. Its most recent funding round raised $6M in July 2024. Xcout tracks 1 named person at Avicenna Biosciences, Inc., including Christopher Meldrum (President).
Avicenna Biosciences, Inc. leadership
- Christopher MeldrumPresident
Avicenna Biosciences, Inc. funding rounds
At least $17.6M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $6M | — | |
| SEC Form D filing | $6M | — | |
| SEC Form D filing | $3M | — | |
| SEC Form D filing | $70,650 | — | |
| SEC Form D filing | $2.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Avicenna Biosciences, Inc. competitors
A few of Avicenna Biosciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
PostEra Inc. is a U.S.-based biotechnology company that develops machine-learning and computational chemistry software for drug discovery and medicinal chemistry. Its platform helps pharmaceutical and biotechnology organizations design, prioritize, and manage experiments for small-molecule therapeutics.
Cime Therapeutics Inc. is a chemistry-first company that provides an automated synthesis platform integrating artificial intelligence and machine learning for drug discovery. The company serves the pharmaceutical and biotechnology sectors by producing novel therapeutic molecules, such as small molecules, molecular glues, and covalent compounds, at high speed and scale.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
Enveda Biosciences (Enveda Therapeutics Inc.) is a biotechnology research company headquartered in Boulder, Colorado. The company leverages artificial intelligence to discover novel therapeutics and chemical compounds derived from natural sources.
Noetik Inc. is an AI-native biotechnology company headquartered in South San Francisco, California, leveraging advanced machine learning methods for biological discovery.
Insitro is a physical artificial intelligence company headquartered in South San Francisco, California, that uses machine learning and data at scale to build a different kind of drug company.
Get Avicenna Biosciences, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Avicenna Biosciences, Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access